Proteomic biomarkers are proteins whose expression levels or modifications are associated with the presence, progression, or response to treatment of cancer. These biomarkers can be detected and quantified in various biological samples such as blood, tissue, or urine, providing valuable information for early diagnosis, prognosis, and personalized treatment strategies.
